Trial Profile
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary) ; Bevacizumab; Temozolomide
- Indications Glioma
- Focus Therapeutic Use
- 04 Jun 2009 New trial record.